Localization of uric acid oxidase activity in core and matrix of peroxisomes as detected in unfixed cryostat sections of rat liver by Van den Munckhof, RJ, Vreeling-Sindelarova, H, Schellens, JP, Frederiks, WM

Get full text

The use of unfixed cryostat sections for electron microscopic study of D-amino acid oxidase activity in rat liver by Schellens, JP, Frederiks, WM, Van Noorden, CJ, Vreeling-Sindelarova, H, Marx, F, McMillan, PJ

Get full text

Myopathy with abnormal structure and function of muscle mitochondria by Hulsmann, W C, Bethlem, J, Meijer, A E, Fleury, P, Schellens, J P

Get full text

A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors by RADEMAKER-LAKHAI, Jeany M, TERRET, Catherine, HOWELL, Stephen B, BAUD, Christiane M, DE BOER, Richard F, PLUIM, Dick, BEIJNEN, Jos H, SCHELLENS, Jan H. M, DROZ, Jean-Pierre

Get full text

Prediction of treatment outcome by cisplatin‐DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin‐radiation (RA... by Hoebers, Frank J.P., Pluim, Dick, Verheij, Marcel, Balm, Alfons J.M., Bartelink, Harry, Schellens, Jan H.M., Begg, Adrian C.

Get full text

Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the... by Terret, C, Zanetta, S, Roché, H, Schellens, J.H.M, Faber, M.N, Wanders, J, Ravic, M, Droz, J.P

Get full text

Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam by van Kesteren, Charlotte, Zandvliet, Anthe S, Karlsson, Mats O, Mathôt, Ron A A, Punt, Cornelis J A, Armand, Jean-Pierre, Raymond, Eric, Huitema, Alwin D R, Dittrich, Christian, Dumez, Herlinde, Roché, Henri H, Droz, Jean-Pierre, Ravic, Miroslav, Yule, S Murray, Wanders, Jantien, Beijnen, Jos H, Fumoleau, Pierre, Schellens, Jan H M

Get full text

A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer by Schoemaker, N E, Kuppens, I E L M, Moiseyenko, V, Glimelius, B, Kjaer, M, Starkhammer, H, Richel, D J, Smaaland, R, Bertelsen, K, Poulsen, J P, Voznyi, E, Norum, J, Fennelly, D, Tveit, K M, Garin, A, Gruia, G, Mourier, A, Sibaud, D, Lefebvre, P, Beijnen, J H, Schellens, J H M, ten Bokkel Huinink, W W

Get full text

Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N‐(3‐chloro‐7‐indolyl)‐1,4‐benzenedisulphonam... by Van Kesteren, Charlotte, Mathôt, R. A. A., Raymond, E., Armand, J. P., Fumoleau, P., Punt, C., Ravic, M., Wanders, J., Beijnen, J. H., Schellens, J. H. M.

Get full text